Joining Akesa as a key advisor in 2019 and a director in 2024, Patrick Davies brings a wealth of experience and strategic insight to the business. He is also currently Chair of Neuren Pharmaceuticals Limited (NEU:ASX) and Senior Advisor at BGH Capital, one of Australia’s largest private equity firms.
With roles including former non-executive Chair of Zuellig Pharma, Asia’s leading healthcare distribution and services provider, Patrick has substantial experience and an extensive network across the APAC region.